How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,595 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Use of intrauterine devices in nulliparous women. (PubMed)

Use of intrauterine devices in nulliparous women. Five intrauterine devices (IUDs) are available in the United States: four levonorgestrel-releasing intrauterine systems (two containing 52 mg, one containing 19.5 mg and one containing 13.5 mg) and one copper-bearing device (Copper T 380A). All IUDs have very low typical-use failure rates and high acceptability ratings, yet they are used by a minority of women, with nulliparous women less likely to do so than parous women. The objective (...) of this clinical review is to give evidence-based recommendations for the use of IUDs in nulliparous women. Intrauterine devices are safe and effective for the majority of women including those who are nulliparous, and should be routinely included in the contraception options offered to them.Copyright © 2016 Elsevier Inc. All rights reserved.

2016 Contraception

182. Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis. (PubMed)

Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis. To estimate the cost-effectiveness of the levonorgestrel intrauterine device (IUD) as an endometrial cancer prevention strategy in obese women.A modified Markov model was used to compare IUD placement at age 50 with usual care among women with a body mass index (BMI, kg/m) 40 or greater or BMI 30 or greater. The effects of obesity on incidence and survival were

Full Text available with Trip Pro

2016 Obstetrics and Gynecology

183. A Dedicated Postpartum Intrauterine Device Inserter: Pilot Experience and Proof of Concept. (PubMed)

A Dedicated Postpartum Intrauterine Device Inserter: Pilot Experience and Proof of Concept. To assess the feasibility, acceptability, and safety of a dedicated postpartum intrauterine device (PPIUD) inserter specifically designed for the post-delivery setting. Primary objectives of fundal placement and expulsion rates were assessed. Secondary objectives were participant satisfaction and IUD retention.In this pilot proof of concept, we enrolled 80 women who presented for PPIUD insertion at 2

Full Text available with Trip Pro

2016 Global health, science and practice

184. Non-visualisation of strings after postplacental insertion of Copper-T 380A intrauterine device. (PubMed)

Non-visualisation of strings after postplacental insertion of Copper-T 380A intrauterine device. To assess the incidence of visible strings of intrauterine contraceptive devices (IUDs) after postplacental insertion following vaginal or caesarean delivery and to establish a management protocol of follow-up visits when strings are not visualised.This was a prospective study of a cohort of 348 women who underwent postplacental insertion of Copper-T 380A IUDs following vaginal or caesarean delivery (...) , the IUD was in situ in 313/348 (89.9%) women. There were eight (2.3%) expulsions and 15 (4.3%) IUD removals. Among women with IUDs in situ, the strings were not visible in 73 (21%) cases. Pelvic ultrasound confirmed intrauterine position of the IUDs in these cases. At 1 year, string visibility was significantly lower after intra-caesarean insertions as compared to vaginal insertions (72.4% vs 98.1%; p<0.05).Visualisation of strings after postplacental vaginal insertion is more common than after intra

2016 Journal of Family Planning and Reproductive Health Care

185. Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment (PubMed)

Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment The present study investigated the combination of levonorgestrel-releasing intrauterine device (LNG-IUD) insertion and palliative radiotherapy (RT) as a potential approach for treating frail, elderly endometrial cancer (EC) patients considered unfit for curative oncological treatments. The inclusion criteria were an age of ≥65 years, pathological (...) confirmation of a uterine neoplasm, a Charlson comorbidity index (CCI) value of ≥4 and the presence of vaginal bleeding. Patients underwent intrauterine insertion of an LNG-IUD, and thereafter, received a total dose of 30 Gy at 3 Gy per fraction, over 10 days. The clinical target volume (CTV) was defined as the uterus and disease-involved tissues in the pelvis plus a 1-cm margin. The planning target volume was obtained by adding a 1-cm isotropic margin to the CTV. A total of 9 patients with EC (median age

Full Text available with Trip Pro

2016 Oncology letters

186. Expanding Access to the Intrauterine Device in Public Health Facilities in Ethiopia: A Mixed-Methods Study (PubMed)

Expanding Access to the Intrauterine Device in Public Health Facilities in Ethiopia: A Mixed-Methods Study In Ethiopia, modern contraceptive prevalence among currently married women nearly tripled over the last decade, but the method mix remains skewed toward short-acting methods. Since 2011, the Integrated Family Health Program (IFHP+), jointly implemented by Pathfinder International and John Snow Inc., has supported the Federal Ministry of Health to introduce intrauterine devices (IUDs

Full Text available with Trip Pro

2016 Global Health: Science and Practice

187. The risk of using intrauterine devices to benign reproductive system conditions in postmenopausal women: A case control study (PubMed)

The risk of using intrauterine devices to benign reproductive system conditions in postmenopausal women: A case control study To investigate the effect of using intrauterine devices (IUDs) during the fertile window on women's reproductive system health.2,744 postmenopausal women in the Minhang District, Shanghai, China were enrolled. In the IUDs group there were 2,253 women; in the tubal ligation group there were 202 women and there were 289 women in the control group. We selected subjects

Full Text available with Trip Pro

2016 Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

188. Uterine Artery Rupture After Induced Abortion and Extraction of an Intrauterine Device (PubMed)

Uterine Artery Rupture After Induced Abortion and Extraction of an Intrauterine Device 26879025 2017 02 01 2018 11 13 2542-5641 129 4 2016 Feb 20 Chinese medical journal Chin. Med. J. Uterine Artery Rupture After Induced Abortion and Extraction of an Intrauterine Device. 484-6 10.4103/0366-6999.176086 Yu Xiao-Ming XM Guan Jing J Department of Reproduction Medicine, Peking University People's Hospital, Beijing 100044, China. Sun Ting-Ting TT eng Case Reports Journal Article China Chin Med J (...) (Engl) 7513795 0366-6999 IM Abortion, Induced adverse effects Adult Device Removal Embolization, Therapeutic Female Humans Intrauterine Devices Pregnancy Uterine Artery Uterine Rupture etiology 2016 2 17 6 0 2016 2 18 6 0 2017 2 2 6 0 ppublish 26879025 ChinMedJ_2016_129_4_484_176086 10.4103/0366-6999.176086 PMC4800852 Obstet Gynecol Sci. 2015 May;58(3):256-9 26023677 Yonsei Med J. 2014 Mar;55(2):367-73 24532505 Clin Radiol. 2015 Dec;70(12):1388-92 26382745 Int J Gynaecol Obstet. 2014 Feb;124(2):176

Full Text available with Trip Pro

2016 Chinese medical journal

189. Intrauterine device infection causing concomitant streptococcal toxic shock syndrome and pelvic abscess with Actinomyces odontolyticus bacteraemia (PubMed)

Intrauterine device infection causing concomitant streptococcal toxic shock syndrome and pelvic abscess with Actinomyces odontolyticus bacteraemia Intrauterine devices (IUDs) are rarely associated with serious infections. We report an unusual concomitant infection of group A Streptococcus (GAS) causing toxic shock syndrome and pelvic abscess with Actinomyces odontolyticus associated with an IUD in a healthy 50-year-old patient. The IUD was subsequently removed and the patient recovered

Full Text available with Trip Pro

2016 BMJ case reports

190. Intrauterine Device

Intrauterine Device Intrauterine Device Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Intrauterine Device Intrauterine Device Aka (...) : Intrauterine Device , IUD , Paragard , Copper T-380A IUD , Progestasert , Mirena , Skyla , Liletta From Related Chapters II. Contraindications: Absolute Undiagnosed Uterine abnormality that distorts endometrial cavity Current intrauterine infection Unresolved abnormal Current endometrial or Findings suggestive of trophoblastic disease or copper allergy (Copper-T IUD) Uterine or pelvic infection within last 3 months III. Contraindications: Historical that are no longer contraindications (restrictions

2018 FP Notebook

191. Intrauterine Device Insertion

Intrauterine Device Insertion Intrauterine Device Insertion Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Intrauterine Device (...) Insertion Intrauterine Device Insertion Aka: Intrauterine Device Insertion , IUD Placement , Difficult IUD Removal , Missing IUD Strings II. Preparation See Contraindications Adverse effects Infection risk reduction Screen for and before placing Antibiotic prophylaxis is not indicated Not indicated for routine prevention Not indicated for Pretreatment Previously ( ) was recommended prior to IUD insertion to make the insertion easier No longer recommended due to no benefit in recent trials and risk

2018 FP Notebook

192. Lidocaine In-situ Gel Before Intrauterine Device Insertion

Lidocaine In-situ Gel Before Intrauterine Device Insertion Lidocaine In-situ Gel Before Intrauterine Device Insertion - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Lidocaine In-situ Gel Before (...) Intrauterine Device Insertion The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02943135 Recruitment Status : Recruiting First Posted : October 24, 2016 Last Update Posted : January 10, 2018 See Sponsor: Assiut University

2016 Clinical Trials

193. Fast Versus Slow Application of Vulsellum During Intrauterine Device Insertion

Fast Versus Slow Application of Vulsellum During Intrauterine Device Insertion Fast Versus Slow Application of Vulsellum During Intrauterine Device Insertion - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Fast Versus Slow Application of Vulsellum During Intrauterine Device Insertion The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02878135 Recruitment Status : Completed First Posted : August 25, 2016 Last Update Posted : August 1, 2017 Sponsor: Assiut University Information provided by (Responsible

2016 Clinical Trials

194. Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion . A randomized double blinded placebo-controlled study. (PubMed)

Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion . A randomized double blinded placebo-controlled study. To determine the effectiveness of diclofenac potassium combined with 2% lidocaine gel in reducing the pain of intrauterine device (IUD) insertion.We randomized 90 parous women requesting copper T380A IUD insertion in a 1:1 ratio to active or placebo treatment. Active treatment included administration of two 50-mg diclofenac potassium tablets 1h before IUD

2016 Contraception

195. A randomized controlled trial of nitrous oxide for intrauterine device insertion in nulliparous women. (PubMed)

A randomized controlled trial of nitrous oxide for intrauterine device insertion in nulliparous women. To evaluate the effectiveness of inhaled nitrous oxide for pain management among nulliparous women undergoing intrauterine device (IUD) insertion.A double-blind, randomized controlled trial was conducted among nulliparous women aged 13-45years who underwent IUD insertion at a US center between October 1, 2013, and August 31, 2014. Using a computer-generated randomization sequence, participants

2016 International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

196. Safety of Intrauterine Devices in Breastfeeding Women: A Systematic Review. (PubMed)

Safety of Intrauterine Devices in Breastfeeding Women: A Systematic Review. To investigate levonorgestrel (LNG)-releasing and copper-bearing (Cu) intrauterine device (IUD) safety among breastfeeding women and, for Cu-IUD use, breastfeeding performance and infant health.Systematic review.We searched PubMed, Embase, Cochrane Library and clinicaltrials.gov for articles through January 2016. We included studies of Cu-IUD or LNG-IUD users comparing IUD-specific (perforation, expulsion) and other

2016 Contraception

197. Medications to ease intrauterine device insertion: A systematic review. (PubMed)

Medications to ease intrauterine device insertion: A systematic review. Potential barriers to intrauterine device (IUD) use include provider concern about difficult insertion, particularly for nulliparous women.This study aims to evaluate the evidence on the effectiveness of medications to ease IUD insertion on provider outcomes (i.e., ease of insertion, need for adjunctive insertion measures, insertion success).We searched the PubMed database for peer-reviewed articles published in any

2016 Contraception

198. Immunologic evaluation of the endometrium with a levonorgestrel intrauterine device in solid organ transplant women and healthy controls. (PubMed)

Immunologic evaluation of the endometrium with a levonorgestrel intrauterine device in solid organ transplant women and healthy controls. The objective was to describe the endometrial milieu of stable transplant patients and healthy women before and after levonorgestrel intrauterine system (LNG-IUS) insertion.Women between 18 and 45 years of age desiring LNG-IUS insertion were enrolled with a 2:1 ratio of healthy to stable solid organ transplant patients. The first visit entailed a blood draw (...) , uterine lavage and endometrial biopsy followed by LNG-IUS insertion. Follow-up visit involved a repeat serum draw, uterine lavage and endometrial biopsy. Cytokine levels were measured in the uterine lavage and serum by quantifying inflammatory biomarkers. Immunohistochemistry staining was performed on the endometrial tissue to measure macrophage levels. Statistical analysis included a nonparametric analysis that compared medians of the marker levels before and after intrauterine device (IUD) insertion

Full Text available with Trip Pro

2016 Contraception

199. Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review. (PubMed)

Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review. Women with depressive or bipolar disorders are at an increased risk for unintended pregnancy.To examine the safety of hormonal contraception among women with depressive and bipolar disorders.We searched for articles published through January 2016 on the safety of using any hormonal contraceptive method among women with depressive or bipolar disorders, including those (...) the menstrual cycle among women with bipolar disorder, whereas mood did significantly change across the menstrual cycle among women not using OCs; one found no significant differences in the frequency of psychiatric hospitalizations among women with bipolar disorder who used depot medroxyprogesterone acetate (DMPA), intrauterine devices (IUDs) or sterilization; and one found no increase in depression scale scores among women with depression using and not using OCs, for both those treated with fluoxetine

2016 Contraception

200. Safety of intrauterine devices among women with HIV: a systematic review. (PubMed)

Safety of intrauterine devices among women with HIV: a systematic review. Use of highly effective contraception among women living with HIV is critical to prevent unintended pregnancy and subsequent risk of maternal complications and perinatal HIV transmission. However, it is not known whether use of intrauterine devices (IUDs) among women with advanced HIV disease poses an increased risk of pelvic infection or HIV progression and transmission.To identify evidence regarding the risk of pelvic

2016 Contraception

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>